VitMode

Proteostasis

A cell's ability to maintain balance between protein production, correct folding, and degradation — a network of mechanisms whose capacity declines with age and is studied as one of the fundamental pillars of cellular aging.

AKdr Anna KowalczykReviewed by dr Piotr ZielińskiUpdated: September 5, 2026
Moderate evidence
4.1

Number of studies

2

Safety

High

Time to effects

Not applicable as a single intervention — this is a descriptive biological framework covering many overlapping processes with different time dynamics.

Who it's for

People interested in the molecular biology of cellular agingPeople wanting to understand the broader context in which autophagy and other cellular 'housekeeping' mechanisms operate
Table of contents

TL;DR

A cell's ability to maintain balance between protein production, correct folding, and degradation — a network of mechanisms whose capacity declines with age and is studied as one of the fundamental pillars of cellular aging.

  • Prevents the accumulation of misfolded and damaged proteins within the cell
  • Provides a theoretical framework linking many other studied aging mechanisms (autophagy, UPRmt, lysosomal function)
  • Good proteostasis is studied as a factor protecting against the accumulation of protein aggregates characteristic of neurodegenerative diseases (mainly data from animal models)
Process typeA network of mechanisms maintaining the balance of protein synthesis, folding, and degradation
Research levelModerate — strong mechanistic evidence from animal models and human cell lines, no direct clinical interventions in humans
Key componentsChaperones (e.g., HSPs), the proteasome, the autophagy-lysosome pathway, UPR/UPRmt responses
Status in aging biologyFormally recognized as one of the 'hallmarks of aging'
Link to autophagyAutophagy is one of the main degradative arms of the proteostasis network
Effects of lossAccumulation of protein aggregates linked in animal-model studies to neurodegenerative diseases

Understand

Overview

Proteostasis (protein homeostasis) is a state of dynamic balance between protein synthesis, correct spatial folding, repair of damaged structures, and the degradation and recycling of those that can no longer be repaired. Maintaining this balance is the job of an extensive 'proteostasis network' — a set of molecular chaperones, degradation systems (the proteasome, the autophagy-lysosome pathway), and stress-response mechanisms that work together to prevent the accumulation of misfolded or damaged proteins.

Proteostasis is recognized as one of the key, interconnected mechanisms in the biology of aging — its capacity steadily declines with age, which in numerous studies on model organisms (yeast, fruit flies, nematodes, mice) is linked to the accumulation of protein aggregates characteristic of neurodegenerative diseases such as Alzheimer's or Parkinson's disease. Loss of proteostasis is formally listed in the scientific literature as one of the recognized 'hallmarks of aging.'

There is no simple, direct way to 'improve proteostasis' in humans — it isn't a single process that can be switched on with a supplement, but a broad network of overlapping mechanisms. The most practically relevant point for a biohacking-minded reader is that proteostasis is closely linked to autophagy — one of its main degradative arms — so factors that influence autophagy (fasting, caloric restriction, physical exercise) also indirectly affect the overall capacity of the proteostasis network.

Mechanism of action

The proteostasis network operates on three interconnected levels. The first is folding quality — molecular chaperones (e.g., the HSP family) help newly formed amino acid chains adopt their correct spatial structure and attempt to repair or refold proteins damaged by cellular stress. The second is selective degradation — proteins that cannot be repaired are tagged (e.g., via ubiquitination) and directed to the proteasome (for single, soluble proteins) or to autophagy (for larger aggregates and damaged organelles), where they end up in the lysosome and are broken down. The third is stress-response programs — such as the response to misfolded proteins in the endoplasmic reticulum (UPR) or in mitochondria (UPRmt) — which, under conditions of cellular overload, further boost chaperone production and degradation capacity.

With age, the capacity of all three levels declines simultaneously: chaperone expression decreases, proteasome activity diminishes, and autophagy and the lysosomes become less efficient. Because these systems are interlinked (e.g., the proteasome and autophagy partially compensate for each other), their combined weakening creates a vicious cycle — a growing amount of damaged protein places additional strain on an already weaker degradation network. It is this cumulative effect, rather than the failure of a single mechanism, that is considered central to age-related loss of proteostasis.

1

Chaperone-assisted folding

Molecular chaperones help newly formed amino acid chains adopt their correct structure and attempt to repair proteins damaged by stress.

2

Selective degradation

Irreparable proteins are tagged and directed to the proteasome or to autophagy-lysosome, depending on the size and type of damage.

3

Activation of stress programs

Under cellular overload, additional responses (UPR, UPRmt) are triggered, boosting repair and degradation capacity.

4

Age-related decline in capacity

Simultaneous weakening of all three levels leads to a growing accumulation of damaged proteins and a vicious cycle of network overload.

Evidence: moderate — based on 2 studies in this database.

Benefits

Prevents the accumulation of misfolded and damaged proteins within the cell
Provides a theoretical framework linking many other studied aging mechanisms (autophagy, UPRmt, lysosomal function)
Good proteostasis is studied as a factor protecting against the accumulation of protein aggregates characteristic of neurodegenerative diseases (mainly data from animal models)

Common myths

MythProteostasis can be 'improved' with a specific supplement the way you raise a vitamin level.

FactProteostasis is a network of many interdependent mechanisms (chaperones, the proteasome, autophagy, stress responses), not a single biochemical parameter — there is no validated intervention today that switches it on as a whole in humans.

MythProteostasis and autophagy are the same concept.

FactAutophagy is one component (one degradative arm) of the broader proteostasis network, alongside chaperones and the proteasome — it's an umbrella term, not a synonym.

Check your profile

Not sure which supplements actually make sense for you?

Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.

Takes about 2 minutesBased on scientific evidence

Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.

Practice

Frequently asked questions

Proteostasis is a broader concept covering the entire network of mechanisms that maintain protein balance (folding, repair, degradation), while autophagy is one of its components — a specific pathway for degrading damaged proteins and organelles.

There is no single, simple clinical test — assessing proteostasis requires combining many indirect indicators (e.g., markers of protein aggregation, proteasome activity), which limits its use outside of scientific research.

Fasting boosts autophagy, which is one arm of the proteostasis network, so it may indirectly support this mechanism — but direct clinical evidence of improvement to the entire proteostasis network in humans is still lacking.

In studies on animal models and cell lines, impaired proteostasis is linked to the accumulation of protein aggregates typical of neurodegenerative diseases, but this is a complex relationship, not a simple cause-and-effect link confirmed clinically in humans.

What to combine with

Good combinations

AutophagyAutophagy is one of the main degradative mechanisms that make up the broader proteostasis network

Lysosomal HealthLysosomes are the final degradation point for autophagy-dependent proteostasis

Safety

Side effects & contraindications

Possible side effects

Contraindications

No significant contraindications at typical doses.

Is it worth taking?

Who it's for

  • People interested in the molecular biology of cellular aging
  • People wanting to understand the broader context in which autophagy and other cellular 'housekeeping' mechanisms operate

Not for

  • No significant contraindications at typical doses.

Evidence

Worth knowing

Loss of proteostasis is formally listed in the scientific literature as one of the recognized 'hallmarks of aging.'

The proteostasis network includes at least three cooperating systems: chaperones, the proteasome, and the autophagy-lysosome pathway.

Studies

The proteostasis network and its decline in ageing

Moderate evidence

Hipp MS, Kasturi P, Hartl FU · Nature Reviews Molecular Cell Biology · 2019

An extensive review describing the structure of the proteostasis network (chaperones, the proteasome, autophagy) and the mechanisms of its gradual weakening with age, linked to neurodegenerative diseases.

View study

Pathways of cellular proteostasis in aging and disease

Moderate evidence

Klaips CL, Jayaraj GG, Hartl FU · Journal of Cell Biology · 2018

A review of cellular proteostasis pathways and evidence for their role in aging and diseases linked to protein aggregation, based largely on studies in model organisms and cell lines.

View study

Sources & bibliography

Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.

Compare with similar entries

About the authors of this entry

AK

Author

dr Anna Kowalczyk

Editor-in-Chief, Molecular Biology

Anna studied molecular biology at the University of Warsaw, then spent eight years after her PhD in a lab researching the mechanisms of cellular aging and autophagy. She stumbled into science journalism almost by accident — frustrated by how easily her field's findings get oversimplified in the media, she started a blog explaining the biology of aging in plain language. That blog became the seed of VitMode. Today Anna oversees the entire editorial process, holding every piece to the same rigor her old lab demanded: primary sources, methodology checks, and honesty about the limits of the evidence. Outside work, she's a dedicated boulderer.

121 publications on this site

PZ

Medical review

dr Piotr Zieliński

Endocrinologist

Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.

174 publications on this site

Published: September 5, 2026Updated: September 5, 2026

Related entries

Zbliżenie na elegancki zegar symbolizujący upływ czasu4.3

Autophagy

An intracellular 'housekeeping' process that clears out damaged proteins and organelles, whose discovery earned a Nobel Prize — one of the key mechanisms studied in the context of slowing aging.

LongevityModerate evidence
Naukowiec w stroju ochronnym badający próbki pod mikroskopem4.0

UPRmt

The mitochondrial unfolded protein response (UPRmt) is an intracellular repair program that protects mitochondria from stress — linked to lifespan extension in model organisms, though the relationship turned out to be more complex than initially thought.

LongevityModerate evidence
Kolorowa, abstrakcyjna reprezentacja nici DNA4.2

TFEB

The transcription factor TFEB acts as a master on-off switch for autophagy and the production of new lysosomes in the cell — one of the best-characterized molecular nodes linking these two processes, studied as a potential target for interventions in aging.

LongevityModerate evidence
Dwoje naukowców prowadzących badania mikroskopowe w laboratorium3.9

Lysosomal Health

Lysosomes — the cell's 'recycling centers' — accumulate unprocessed waste and lose capacity with age, a pattern increasingly described as one of the fundamental, shared denominators of cellular aging and a potential target for future interventions.

LongevityEarly-stage evidence
Kolorowy widok mikroskopowy struktury komórkowej4.0

Mitophagy

A selective form of autophagy in which the cell recognizes and removes specifically damaged, dysfunctional mitochondria — a mitochondrial quality-control mechanism whose efficiency declines with age and is studied in the context of neurodegenerative disease.

LongevityEarly-stage evidence
Osoba siedząca na kanapie i trzymająca się za bolące kolano4.3

Inflammaging

Chronic, low-grade, systemic inflammation that accompanies aging even without an active infection — a term coined in 2000 by Claudio Franceschi, today considered one of the fundamental mechanisms linking aging to age-related disease.

LongevityModerate evidence

Related articles

Zabytkowy budzik rzucający długi cień na ścianęPoradniki

Intermittent Fasting 16:8 or 5:2 — Which Eating Window Should You Choose

Intermittent fasting has spawned dozens of variants, but two protocols have dominated the public imagination: the daily, restricted 16:8 eating window and the cyclical, stronger calorie restriction of the 5:2 method. This guide compares both approaches based on real clinical trials, showing that the choice between them rarely comes down to which one is 'better' — and more often to which one you can actually stick with for longer than a few weeks.

PZdr Piotr Zieliński12 min

September 3, 2026

Zbliżenie na dłoń naukowca w rękawiczce trzymającą kapsułkę żelową w laboratoriumBadania naukowe

What we now know about NMN and longevity — a review of human studies

NMN, a precursor of NAD+, has for years been one of the most hotly debated supplements in the biohacking community. We look at what the latest clinical trials in humans show, as distinct from earlier studies in mice.

MNMichał Nowak7 min

August 11, 2026

Widok z góry na różnorodne suplementy i witaminy na marmurowym blacieBadania naukowe

Longevity Vitamins: Which Supplements Actually Have Real Scientific Evidence Behind Them

Every supplement shelf promises a longer life in every capsule, but the hard data from large clinical trials tells a far more measured story. We go through which vitamins genuinely extend healthy lifespan in people with a real deficiency, and which — despite their popularity — have no supporting evidence at all, or worse, evidence of no benefit.

AKdr Anna Kowalczyk15 min

August 20, 2026

Naukowiec trzymający pipetę w niebieskich rękawiczkach w laboratoriumPoradniki

NMN vs NAD+ vs Resveratrol — What Actually Extends Life?

Three of the biggest names in longevity, one shared hypothesis, and a very different level of evidence in humans for each. An honest comparison of mechanism, clinical trial quality, and monthly cost — with no marketing rounding up.

PZdr Piotr Zieliński14 min

August 20, 2026

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.